Inventor · disambiguated record
David Andrew
Also filed as: ANDREW DAVID · ANDREW DAVID P
10 granted patents·7 pending applications·232 citations·filing 1999–2024
91Inventor score
Top patents by PatentIndex Score
17 records- 0189US6488930B1Anti-CCR4 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 1999·Granted Dec 3, 2002·99 cites·64 claims
- 0288US7138117B1Anti-CCR4 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2002·Granted Nov 21, 2006·43 cites·28 claims
- 0387US6936248B1Methods of inhibiting GPR-9-6 functionMILLENNIUM PHARM INC·Filed 2000·Granted Aug 30, 2005·22 cites·71 claims
- 0485US6689570B2Methods of identifying agents which bind GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Feb 10, 2004·17 cites·50 claims
- 0583US7381412B2Anti-TECK antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2005·Granted Jun 3, 2008·4 cites·4 claims
- 0682US6884574B2Methods of identifying agents which inhibit GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Apr 26, 2005·12 cites·35 claims
- 0780US6329159B1Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 functionMILLENNIUM PHARM INC·Filed 1999·Granted Dec 11, 2001·30 cites·43 claims
- 0878US12441789B2DLL3-targeting antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Oct 14, 2025·1 cites·17 claims
- 0971US7485301B2Methods of treating inflammatory disease using antibodies which bind GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Feb 3, 2009·3 cites·19 claims
- 1068US2024360202A1Anti-hpv antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1165US7566536B2WNT-regulated cytokine-like polypeptide and nucleic acids encoding sameCURAGEN CORP·Filed 2003·Granted Jul 28, 2009·1 cites·29 claims
- 1262US2024216557A1Radioligand binding to anti-dll3 antibodies for pretargeted pet imaging and therapeutic uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1362US2024368269A1Anti-dll3 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1454US2024115721A1Anti-dll3 antibody-drug conjugateMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1554US2024115720A1Antibody-pyrrolobenzodiazepine derivative conjugateMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1651US2007031896A1Anti-CCR4 antibodies and methods of use thereforWU LIJUN·Filed 2006·Application pending·0 cites
- 1742US2003082757A1Novel proteins and nucleic acids encoding sameFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →